T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASCMA
1726
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $921K | ﹤0.01% |
59,855
+8,300
| +16% | +$135K |
|
1727
UMB Financial
UMBF
$11.4B
| $918K | ﹤0.01% |
17,248
+40
| +0.2% | +$2.17K |
|
|
MDR
1728
DELISTED
McDermott International
MDR
| $915K | ﹤0.01% |
61,717
+16,067
| +35% | +$217K |
|
1729
Universal Display
OLED
$4.23B
| $910K | ﹤0.01% |
13,429
+29
| +0.2% | +$1.78K |
|
1730
MillerKnoll
MLKN
$1.64B
| $909K | ﹤0.01% |
30,400
| – | – |
|
|
EDR
1731
DELISTED
Education Realty Trust Inc
EDR
| $907K | ﹤0.01% |
19,667
+2,447
| +14% | +$103K |
|
|
JUNO
1732
DELISTED
Juno Therapeutics, Inc.
JUNO
| $907K | ﹤0.01% |
23,600
-166,829
| -88% | -$6.92M |
|
1733
Sturm, Ruger & Co
RGR
$600M
| $906K | ﹤0.01% |
14,150
+2,700
| +24% | +$174K |
|
|
DBD
1734
DELISTED
Diebold Nixdorf Incorporated
DBD
| $903K | ﹤0.01% |
36,360
| – | – |
|
|
EFII
1735
DELISTED
Electronics for Imaging
EFII
| $902K | ﹤0.01% |
20,947
-2,773
| -12% | -$117K |
|
|
MENT
1736
DELISTED
Mentor Graphics Corp
MENT
| $900K | ﹤0.01% |
42,314
+34
| +0.1% | +$707 |
|
|
XRM
1737
DELISTED
Xerium Technologies Inc (new)
XRM
| $894K | ﹤0.01% |
140,054
-49,000
| -26% | -$296K |
|
|
BLD
1738
DELISTED
TopBuild
BLD
| $893K | ﹤0.01% |
24,664
+42
| +0.2% | +$1.42K |
|
1739
Wendy's
WEN
$1.65B
| $891K | ﹤0.01% |
92,634
| – | – |
|
|
DMC
1740
Del Monte Corp
DMC
$1.42B
| $888K | ﹤0.01% |
16,320
| – | – |
|
1741
Shenandoah Telecom
SHEN
$721M
| $884K | ﹤0.01% |
22,620
+1,000
| +5% | +$30.9K |
|
1742
CACI
CACI
$15B
| $875K | ﹤0.01% |
9,676
+16
| +0.2% | +$1.59K |
|
|
LOCK
1743
DELISTED
LifeLock, Inc.
LOCK
| $874K | ﹤0.01% |
55,264
-36
| -0.1% | -$471 |
|
|
JOY
1744
DELISTED
Joy Global Inc
JOY
| $865K | ﹤0.01% |
40,908
-1,987
| -5% | -$37.5K |
|
1745
Apple Hospitality REIT
APLE
$3.71B
| $863K | ﹤0.01% |
45,877
-13
| -0% | -$244 |
|
1746
Unifirst Corp
UNF
$5.24B
| $863K | ﹤0.01% |
7,460
+1,710
| +30% | +$191K |
|
1747
GameStop
GME
$8.33B
| $861K | ﹤0.01% |
129,616
-649,384
| -83% | -$4.75M |
|
1748
Brookfield
BN
$110B
| $859K | ﹤0.01% |
73,151
-1,171
| -2% | -$14K |
|
1749
Liberty Broadband Class A
LBRDA
$5.07B
| $856K | ﹤0.01% |
14,409
+10
| +0.1% | +$583 |
|
1750
Crane NXT
CXT
$2.96B
| $853K | ﹤0.01% |
43,306
-6,011
| -12% | -$117K |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.